Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHRISTOPHER SERRONE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1366830945
CMS profile
11100418
Location
CHANDLER, AZ

General Payments · PY2021–2023

$933.78

  • Reported across 56 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$265.37

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $244.91 14
Entertainment $20.46 1

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $31.85 2
Nevro Corp. $29.98 1
IDORSIA PHARMACEUTICALS US INC $29.90 2
Acerta Pharma LLC $28.41 2
Lilly USA, LLC $28.33 2
DEXCOM, INC. $23.79 1
Antares Pharma, Inc. $20.85 1
OPTOS, INC. $20.46 1
Abbott Laboratories $20.32 1
GlaxoSmithKline, LLC. $15.98 1
IMPULSE DYNAMICS (USA) INC. $15.50 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $288.40 17
PY2022 $380.01 24
PY2023 $265.37 15

Payment records · PY2023 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $20.32 05/17/2023 Food and Beverage Undisputed 01/23/2026 1019058601 CMS
Antares Pharma, Inc. $20.85 06/01/2023 Food and Beverage Undisputed 01/23/2026 1054665101 CMS
AstraZeneca Pharmaceuticals LP $15.50 02/27/2023 Food and Beverage Undisputed 01/23/2026 1014258883 CMS
AstraZeneca Pharmaceuticals LP $12.91 05/02/2023 Food and Beverage Undisputed 01/23/2026 1015841489 CMS
Dexcom, Inc. $23.79 04/28/2023 Food and Beverage Undisputed 01/23/2026 1054580133 CMS
GlaxoSmithKline, LLC. $15.98 01/10/2023 Food and Beverage Undisputed 01/23/2026 1004335233 CMS
IDORSIA PHARMACEUTICALS US INC $16.97 03/08/2023 Food and Beverage Undisputed 01/23/2026 1034391889 CMS
IDORSIA PHARMACEUTICALS US INC $12.93 06/07/2023 Food and Beverage Undisputed 01/23/2026 1034391897 CMS
Impulse Dynamics (USA) Inc. $15.50 05/01/2023 Food and Beverage Undisputed 01/23/2026 1022373253 CMS
Lilly USA, LLC $15.50 02/10/2023 Food and Beverage Undisputed 01/23/2026 1032863087 CMS
Lilly USA, LLC $12.83 04/24/2023 Food and Beverage Undisputed 01/23/2026 1032820863 CMS
Nevro Corp. $29.98 02/01/2023 Food and Beverage Undisputed 01/23/2026 1051644329 CMS
Novo Nordisk Inc $14.25 01/17/2023 Food and Beverage Undisputed 01/23/2026 1001156737 CMS
Novo Nordisk Inc $17.60 05/09/2023 Food and Beverage Undisputed 01/23/2026 1001156747 CMS
Optos, Inc. $20.46 04/05/2023 Entertainment Undisputed 01/23/2026 1052410145 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.